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Background: Although the benefits of comprehensive pulmonary rehabilitation have been
demonstrated in patients with COPD, the effects of exercise sessions within self-management
programs remain unclear. We hypothesized that 8 supervised exercise sessions incorporated in
a 1-month self-management education program in COPD patients would be effective to improve
health outcomes and to reduce direct medical costs after one year, compared to usual care.
Methods: In this randomized controlled trial, 38moderate-to-severeCOPD patientswere assigned
either to an intervention group or to a usual care group. The hospital-based intervention program
provided a combination of 8 sessions of supervised exercise with 8 self-management education
sessions over a 1-month period. The primary end-point was the 6-min walking distance (6MWD),
with secondary outcomes being health-related quality of life (HRQoL) e using the St. George’s
RespiratoryQuestionnaire (SGRQ)andNottinghamHealthProfile (NHP),maximal exercise capacity
and healthcare utilization. Data were collected before and one year after the program.
Results: After 12 months, we found statistically significant between-group differences in favor of
the intervention group in 6MWD (þ50.5 m (95%CI, 2 to 99), in two domains of NHP (energy, 19.8
(38 to1);emotional reaction,e10.4 (20 to 0)); in SGRQ-symptoms (14.0 (23 to5)), and in
cost of COPD medication (480.7 V (CI, 891 to 70) per patient per year).
Conclusion: The present hospital-based intervention combining supervised exercise with self-
management education provides significant improvements in patient’s exercise tolerance and
HRQoL, and significant decrease of COPD medication costs, compared to usual care.
ª 2010 Elsevier Ltd. All rights reserved.7 601 123; fax: þ33 467 415 708.
v-montp1.fr (G. Ninot).
0 Elsevier Ltd. All rights reserved.
378 G. Ninot et al.Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a serious
public health problem. According to the World Health Organi-
zation, COPD is currently the fourth leading cause of mortality
worldwide, with approximately 2,75 million deaths yearly and
a further increase inmortality predicted for the coming years.1
Since many patients with COPD exhibit progressive disability
rather than immediate death, mortality data do not present
a complete picture of the disease’s burden.1 In addition to the
economic burden imposed on healthcare systems, a loss in
health-related quality of life is seen in many patients. There-
fore, appropriate therapies are necessary to deal with this
disease.
Self-management is a term applied to any formalized
patient educationprogramaimedat teaching skills needed to
carry out disease-specific medical regimens, guide health
behavior change, and provide emotional support to enable
patients to control their disease and live functional lives. The
influence of self-management education in patients with
COPD is not clear since previous studies that have addressed
the issue have used a variety of programs.2 Some investiga-
tions, for example, added action plans and/or exercise
interventions to the self-management education program.
The type and intensity of the education component also
varies across studies from group education to individual
education to written education only. The effectiveness of
pulmonary rehabilitation and, more specifically, of exercise
training, has been extensively documented using both inpa-
tient3 and outpatient approaches.4 However, the effects of
exercise interventions administeredwithin self-management
programs remain unclear andhavebeen the focus of only four
studies.5e8 The exercise programs included in these investi-
gations did not systematically meet rehabilitation standards
(e.g., frequency and intensity of supervised training sessions)
and non-participation was not a criterion for study with-
drawal, thus affecting the uniformity of interventions
offered. Moreover, only two studies9,10 have evaluated the
cost-effectiveness of such self-management program, i.e.
comprising education and exercise components, with only
the Quebec study of Bourbeau et al.10 which showed signifi-
cant benefits. Given the current context of financial uncer-
tainty, there is a need formore randomized controlled trial to
achieve more evidence about the cost-saving effect of
exercise interventions incorporatedwithin self-management
education programs, compared to usual care.
Therefore, the objective of the present study was to
determine the 1-year beneficial effect of a self-management
education program which included supervised exercise
sessions.Theprimaryoutcomemeasurewas the6-minwalking
distance (6MWD). Secondary outcome measures were health-
related quality of life (HRQoL),maximal exercise capacity and
direct medical costs.
Methods
Design
This study followed a prospective, randomized, parallel-
group design. It was part of a wider study investigating
the effects of a self-management education program onhealthcare costs for various chronic diseases, including
chronic heart failure, type-2 diabetes11 and COPD. Patients
were recruited from pulmonary clinics in a university-based
hospital between January 2002 and November 2003. This
center had extensive prior experience in providing pulmo-
nary rehabilitation. Participants were randomly assigned
either to usual care without any practical intervention
(control group) or to a 4-week standardized, comprehen-
sive, self-management program comprising education and
exercise sessions. After the 4-week intervention, partici-
pants were encouraged to continue exercising at home, and
were followed-up for 48 weeks to complete the 1-year
study. During the maintenance phase (1e12 months),
contacts with study personnel were limited (for both
groups) to telephone interviews to reinforce the impor-
tance of exercise and to ask about adverse events. Partic-
ipants from both groups were assessed at inclusion and at 1
year. The institutional research ethic board approved the
study, and each patient provided informed consent.
Participants
Participantswere recruited from theuniversity-based center
by flyers advertizing the study. Patients were eligible for
participation if they had stable COPD, that is, no change in
medication and symptoms (i.e. dyspnea, volume, or color of
sputum) for at least 4 weeks before screening; were 40 years
of age or older and had a forced expiratory volume in 1 s
(FEV1)/forced vital capacity (FVC) ratio of less than 0.70. No
participant had previously been involved in pulmonary
rehabilitation or had lived in a long-term care facility.
Everyone understood, read, and wrote French. Exclusion
criteria included a previous diagnosis of asthma, oxygen
dependence, unstable and/or uncontrolled cardiac disease,
musculoskeletal problems precluding exercise training,
a terminal disease, dementia, or an uncontrolled psychiatric
illness.
Intervention
Self-management program
The self-management program was provided in the hospital
on an outpatient basis. A health professional gave 8
lectures to small groups of 4e8 participants at a rate of 2
sessions (i.e. 2 h per session) per week for 4 weeks. The
program emphasized on the acquisition of self-management
skills: to promote smoking cessation, encourage prompt
management of acute exacerbation (e.g., advice about
when to initiate antibiotics or steroid regimens), ensure
correct inhaler techniques, ensure right secretion removal
techniques, optimize nutrition and promote active lifestyle
(particularly exercise). After each educational session
within the same group, participants performed the usual
exercise program used in our laboratory12 (i.e. cycling at
the level of the ventilatory threshold for 30e45 min under
the supervision of a qualified exercise trainer). The
provider was insisted on the use of correct breathing
techniques during exercise.
Wedefinedadherence to the self-managementprogramas
completing at least seven of the eight sessions e combining
exercise and education components.
Exercise and education in self-management program 379Usual care intervention (UC)
Patients assigned in UC group were discharged from
hospital by the attending physician who decided on the
outpatient control regime. Patients in the UC group were
visited by their own physician without additional support.
Specifically, the controls did not benefit from the self-
management program (neither the education nor the
exercise components).
Follow-up strategy
Themaintenance programwas identical in both groups; it did
include neither supervised training sessions nor education
sessions. There was only a telephone support (i.e. 3 times
during the follow-up period) which consisted of standardized
contact of patientse encouragement to follow personalized
endurance-training (i.e. home exercise, moderate intensity,
2 times per week) e and relied on reporting of symptoms.
Randomization
Participants were randomly assigned either to the self-
management program or usual care group. The trial statis-
tician,MCP, generated the randomallocation sequence using
the random procedure in SAS (SAS v.9.1e SAS Institute, Cary
NC), with a 1:1 allocation using block size of 4. The enroll-
ment of patients in the study proceeded as follows: (i)
patients were contacted via flyers advertizing the study in
the corridors of the hospital; (ii) they met the investigator
(i.e. physician) who informed them about the objective of
the study; and he verified their eligibility; (iii) eligible
patients were invited to participate in the study. After the
physician had obtained the patient’s consent, he sent by fax
the randomization form to the Clinical Research Unit (AJ) for
allocation consignment re-addressed by fax. He subse-
quently informed patients of their group allocation. Due to
the nature of the intervention conditions, it is not possible to
blind research participants or assessors. Several stratagems
were adopted in an effort to ensure that objectivity was
maintained as rigorously as possible. Participants were
unaware of their group allocation until they had completed
all of their pre-intervention assessment. The individuals
carrying out the assessments were not part of the interven-
tion team. Research participants were asked not to divulge
information regarding their group allocation in conversation
during assessments at 12 month.
Measurements and outcomes
Evaluation visits were scheduled at the study center at
enrollment (initial visit) and at 12 months (end of study).
Patients from both groups kept a diary to help collect
information on medical events and physical activity.
Primary outcome variable
The pre-specified primary outcome was the change in
6MWD at 12 months to measure the impact of self-
management program including exercise training.
Secondary outcome variables
Secondary outcomes included domains of the St. George’s
RespiratoryQuestionnaire (SGRQ) and theNottinghamHealthProfile (NHP), maximal exercise capacity (measured as peak
work rate), daily physical activity and healthcare utilization
at 12 months.
Six-minute walking test
The 6MW test was performed twice with more than 30 min
between tests to allow heart rate and dyspnea to return to
their initial resting values. Subjects were asked to walk,
during 6min, at their ownmaximal pace along a perimeter of
30 m. No encouragement was given, and subjects were
informed each minute of the time remaining. A dyspnea
score was measured on a visual analog scale (VAS, 0e10 cm)
before and at the end of the test. The minimum, clinically
important difference (MCID) was set at 35 m for the 6MWD.13
COPD-specific health status questionnaire
Patient completed the French version of the SGRQ. This
validated 50-item questionnaire14,15 has been widely used
in patients with COPD. The SGRQ is composed of three
domains: symptoms, activity and impacts. Scores range
between 0 (no impairment) and 100 (worst possible health).
A difference 4.0 units is considered as the MCID.16
Generic health status questionnaire
Perceived health status was measured according to the first
part of the NHP, developed in the UK in the 1970s for use in
population surveys.17 This self-administered instrument,
validated in a French version,18 consists of 38 items per-
taining to how people feel or operate in their daily life. The
items cover the following six dimensions: physical mobility,
pain, sleep, energy, social isolation and emotional reac-
tions. Patients were asked whether or not each item
applied to them. Positive answers were given the appro-
priate weight, resulting in score range from 0 to 100 for
each dimension. Dimension scores were only calculated if
no data were missing on the dimension concerned. Higher
scores correspond to a lower perceived health status.
Maximal exercise test
At the time of enrollment and at 12 month, each patient
completed a symptom-limited, incremental cycle exercise
test todeterminepeakworkcapacity.The testwasperformed
on an electromagnetically-braked cycle ergometer following
the individualized protocol usually used in our laboratory and
recommended by the American Thoracic Society.19
Daily physical activity
Physical activity level was measured using the Voorrips
questionnaire20 at the time of enrollment and at 12 month.
This questionnaire provides a reliable and valid method for
classifying the activity level of older subjects as high,
medium or low with a score of 9.4 or less indicating a low
physical level, thus classifying the subject as being seden-
tary.21 Moreover, to ensure “realistic” conditions of training
at home, during the follow-up, the actual practice of the
physical activity were recorded: everyday, patients had to
keep track of all their activity in a diary.
Healthcare utilization
Assessment of the use of healthcare resources by individual
interviews was carried out after 12 months in both arms of
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Figure 1 Study Flow Diagram (as recommended by CONSORT
guideline).
380 G. Ninot et al.the study. Also, data concerning the number and length of
hospital admissions were retrieved from patients’ medical
chart.
Pulmonary function tests
Flow rates, lung volumes, and diffusion capacity were
measured using standard techniques21,22 at the time of
enrollment. Spirometry was repeated at 12 months.
Safety monitoring
Patients were asked to complete a weekly diary card during
the study period to record medical events, such as COPD
exacerbations, hospitalizations, cardiovascular events, or
any other relevant event. Serious adverse events were
defined as death or hospitalizations for any cause and were
tracked throughout the study during the standardized
telephone interviews. The investigators and the study
steering committee reviewed all serious adverse events to
determine whether they were related to the study
intervention.
Sample size calculation
We calculated that we would need a study of 23 patients to
have an 80% chance of detecting a difference of 50 m
between-group means in 6MWD e derived from the overall
effect size of a rehabilitation program calculated in the
review of Lacasse et al.23 e with an SD of 65 m and an alpha
error of 0.05 (one-sided).
Statistical analysis
Measures of central tendency and dispersion were computed
for quantitative baseline measures, while proportions were
obtained for categorical measures. Differences are reported
as outpatient intervention minus usual care intervention.
Only the patients with complete final outcome data were
included in the main analyses. For the primary outcome e
6MWD e the within-group differences were calculated from
baseline, and 95% CIs were obtained (with a fixed effects
regression model), adjusting for baseline 6MWD and using
treatment group as a predictor. Separate regression analyses
were used to predict treatment differences at 12 month. A
series ofGeneral LinearModel (SAS v.9.1e SAS Institute, Cary
NC) were conducted to estimate adjusted treatment differ-
ences and within-group differences. Secondary outcomes
were analyzed using the sameanalyses. All tests of statistical
significance were 2-sided.
Results
Study patients
Fig. 1 displays the patients’ flow throughout the study.
Between 2002 and 2003, we assessed 101 patients for
eligibility and randomly assigned 45 patients. Fifty-six
patients did not meet all inclusion criteria and 16 refused to
participate without financial compensation. One patient
from the intervention group did not fulfill our adherence
criteria to the 4-week program, and also did not complete
the 1-year evaluation. Six more patients were not available
for follow-up evaluation: four in the usual care group, andtwo in the intervention group. The withdrawals were due to
miscellaneous medical conditions (n Z 3), and COPD
exacerbation (n Z 3). Due to the missing data, we did not
retain these patients in our 1-year analyses.
Sample characteristics
Table 1 summarizes selected descriptive characteristics in
all 38 eligible COPD patients. As indicated, at entry,
patients from both groups showed similar characteristics
except for total lung capacity, which was significantly
higher in usual care group (p Z 0.02). Baseline character-
istics of the patients who withdrew from the study were
similar to those of patients who completed the trial:
Patients who withdrew were aged 67 ys (SD  11 yrs) and
had a predicted FEV1 value of 47% (SD  17%) and a 6MWD of
388 m (SD  79 m).
Primary outcome
Table 2 shows changes (difference between 12 months and
baseline) in clinical, functional and quality of life variables,
by treatment group, as well as the difference of this change
in the intervention group compared to the usual care group,
which is equal to the coefficient of the linear regression
model.
Table 1 Baseline Characteristics of Patients.
Usual Care Group (n Z 18) Intervention group (n Z 20)
Sociodemographics
Age, y 61 (56e65) 65 (59e74)
Men/women, n/n 14/4 18/2
Employed, n (%) 3 (17) 1 (5)
Distance from hospital, km 15 (5e30) 8 (5e28)
Clinical and functional profile
Current smoker, n (%) 5 (28) 5 (25)
Ever smoked, n (%) 17 (94) 19 (95)
Body-mass index, kg/m2 26 (22e27) 25 (23e28)
Mood disorder, n (%) 4 (22) 3 (16)
FEV1, L 1.52 (1.06e1.85) 1.69 (1.17e2.01)
FEV1, % predicted 54 (42e57) 56 (42e67)
FVC, L 3.10 (2.44e3.53) 2.85 (2.50e3.59)
FVC, % predicted 77 (72e84) 75 (65e92)
FEV1 e FVC ratio, % 49 (41e58) 56 (53e59)
Total Lung Capacity, % predicted 110 (103e127) 101 (88e114)
Six-minute walking distance, m 397 (360e470) 450 (385e505)
Baseline dyspnea VAS score (end of 6MWD) 5.5 (4e6) 6.2 (5e8)
Peak work rate, W 80 (50e100) 76 (62e105)
Peak VO2, mL
1 kg1 min1 26 (23e28) 24 (22e28)
Baseline Voorrips score 2 (1e4) 3 (2e4)
Baseline SGRQ score
Symptoms 46 (34e61) 47 (22e70)
Activity 51 (41e79) 54 (45e67)
Impacts 28 (17e45) 36 (16e47)
Total 41 (27e51) 44 (26e56)
Baseline NHP score
Energy 44 (26e100) 27 (0e63)
Pain 5 (0e18) 11 (0e22)
Emotional reaction 19 (8e40) 9 (0e29)
Sleep 26 (0e57) 32 (0e52)
Isolation 10 (0e25) 0 (0e0)
Mobility 12 (0e23) 16 (0e33)
Data are expressed as median (25th to 75th percentile), n or n/n; SGRQZ St. George’s Respiratory Questionnaire; NHP Z Nottingham
Health Profile.
Exercise and education in self-management program 381The within-group comparisons for the primary outcome
showed that only the intervention group was associated
with statistically significant improvements in 6MWD at 12
month (Table 2). Moreover, after adjustment for the
baseline value, results showed that the intervention group
walked 50.5 m (95%CI: 2e99 m) farther than the usual care
group (Table 2). In the same period, the results indicate no
significant between- or within-group difference in dyspnea
(post 6MWD) scores.
Secondary outcomes
A clinically significant between-group difference was
observed for symptoms of SGRQ 12 months after the begin-
ning of the study. In addition, the score in the intervention
group improved for all four domains of the SGRQ and the
energy and emotional reactiondomains of theNHP. The usual
care groupwas also associatedwith statistically and clinically
significant improvement in the activity dimension of the
SGRQ. No effect was found for other domains of the NHP.Both groups showed significant increases in the total
Voorrips scores, with higher values at 1-year than at
admission (intervention group: þ4.1, p < 0.001; usual care
group þ1.4, p < 0.001). Also, subgroup comparisons
revealed a significant difference after one year with higher
scores for the intervention group (2.7 (95% CI: 1.1e4.3
units)). Given that a large majority of patients forgot to
keep track of their daily physical activity in their diary, we
did not analyze this data.
Results indicate no significant between-group difference
in maximal exercise capacity (peak work rate or _VO2max
values). Nevertheless, the intervention group shows a signifi-
cant increase of peak work rate values after 12 months.
Regarding healthcare utilization, the number of days
spent in the hospital for respiratory problems and for all
causes, aswell as theassociatedcost perpatient andper year
did not differ between groups after 12 months (Table 2).
Nevertheless, a decrease in COPDmedication cost was noted
in the follow-up period for the intervention group (481 V
(95% CI:e891 to 70) per patient and per year).
le 2 6MWD, Dyspnea, Peak Work Rate, Peak VO2, Voorrips Score, NHP Score, SGRQ Score and HealthCare Us s from Baseline to 12 month.
able Within-Group Differences from Baseline
(Median, 25th to 75th percentile)
een-group Difference
rvention Minus Usual Care group)
Usual Care group (n Z 18) Intervention group (n Z ariate
ysis
Linear regression
1 yr P 1 yr P b (95%CI) P
in walking distance, m 12.5 (e15 to 48) 0.52 30.0 (5 to 80) <0 50.5 (2e99) 0.04
nea VAS score (end of 6MWD) 0.0 (1 to 1.50) 0.90 1.0 (e3.25 to 0.75) 0.06 0.5 (e2 to 1) 0.52
k work rate, W 8.0 (0 to 20) <0.01 0.0 (e4 to 11) 0.45 6.3 (e15 to 3) 0.17
k VO2, mL
1 kg1 min1 0.1 (e0.1 to 0.1) 0.90 0.1 (e0.2 to 0.1) 0.50 0.03 (e0.2 to 0.1) 0.76
rrips total 1.4 (0.6 to 2.3) <0.001 4.1 (2.5 to 6.7) <0 001 2.7 (1.1e4.3) <0.01
score
rgy 0.0 (e39 to 0) 0.18 L13.3 (e63 to 0) 0.03 19.8 (e38 to 1) 0.04
0.0 (e10 to 6) 0.97 5.7 (e12 to 5) 0.11 4.7 (e14 to 5) 0.32
tional reaction 0.0 (e8 to 0) 0.66 L8.2 (e18 to 0) 0.03 10.4 (e20 to 0) 0.04
p 0.0 (0e20) 0.17 0.0 (e1 to 0) 0.68 12.2 (e26 to 1) 0.07
tion 0.0 (e17 to 0) 0.68 0.0 (0e25) 0.84 8.5 (e20 to 3) 0.15
ility 0.0 (e3 to 1) 0.99 0.0 (e13 to 5) 0.23 2.2 (e10 to 6) 0.58
Q score
mptoms 3.7 (e8 to 18) 0.31 L7.0 (e19 to 1) 0.02 14.0 (e23 to 5) <0.01
tivity L6.7 (e13 to 0) 0.03 L6.7 (e16 to e5) <0 2.8 (e13 to 7) 0.58
pacts 5.6 (e9 to 9) 0.52 L6.3 (e24 to 0) 0.04 8.9 (e19 to 1) 0.08
l 4.7 (e11 to 4) 0.33 L7.6 (e18 to e1) <0 8.0 (e16 to 0) 0.06
D-related hospital LOS#, day 0.0 (e1 to 0) 0.50 0.0 (e3 to 0) 0.64 1.7 (e1 to 4) 0.18
ause hospital LOS#, day 0.0 (0e2) 0.94 0.0 (e3 to 0.5) 0.71 1.2 (e1 to 4) 0.34
of COPD medication#, V 9.6 (e17 to 157) 0.76 L6.5 (e179 to 0) 0.02 480.7 (e891 to 70) 0.02
of COPD-related hospitalizations#, V 0.0 (e1017 to 0) 0.44 0.0 (e2879 to 49) 0.67 1690.8 (e812 to 4194) 0.18
of all cause hospitalizations#, V 0.0 (0e2035) 0.94 0.0 (e2905 to 509) 0.62 1110.0 (e1551 to 3771) 0.40
lts presented as: y Z mean (95% confidence interval) or z Z median (25th to 75th percentile); # Z per patient and S Z length of stay. Regression coefficient b (95%
dence interval) of variable ‘group’, adjusted for the baseline value of the outcome measure concerned.
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Main results
The objective of this randomized controlled study was to
determine the beneficial effect of a 1-year self-manage-
ment program which provided supervised exercise and
education sessions. After one year, the program was asso-
ciated with a statistically significant difference in 6MWD,
daily physical activity level, HRQoL (NHP e energy and
emotional reaction, SGRQ e symptoms) and costs of COPD
medication compared to usual care. Administering a simple
intervention that combined supervised exercise with stan-
dard self-management education yield small but significant
benefits compared to usual care.
Exercise tolerance
Given that the inferior limit of the confidence interval
around our effect size (2e99 m) lies below the limit of the
confidence interval around the estimate of the MCID for the
6-min walking test (CI: 30e42 m),13 the clinical significance
of our result is low. This finding parallels those of Boxall
et al. (CI: 8e92 m) who also included the 6MWD as an
outcome measure of a self-management education program
with supervised exercise. Their shorter follow-up period
(i.e. 3 months) renders comparisons with our trial difficult.
With a comparable 12-month follow-up, our results on
exercise tolerance and dyspnea do contrast those of two
larger randomized study from Bourbeau et al. (CI: 44 to
26 m) and Monninkhof et al. (CI: 47 to 1 m), where the
exercise program was not an obligatory component of the
intervention. It is not clear in these prior studies how many
patients really participated in the exercise program. The
standardized supervision of exercise in our intervention
(i.e. 8 sessions) may be an explanation for our better result.
Furthermore, the fact that our patients showed a similar
COPD severity (FEV1 w 1.5 L) and baseline exercise toler-
ance (6MWD w 420 m) to those of Monninkhof et al.,7
makes the confounding effect of these two known factors
on the 6MWD’s change unlikely.
Despite the large confidence interval of our effect size,
our results are positive and suggest that peer interactions
and exercise in the self-management education program
may be necessary for letting patients acquire and practice
skills, and for achieving more active behavioural change
and better dyspnea control. Patients learn with experts to
cope with their spontaneous anxiety provoked by dyspnea
during exercise.24
Healthcare utilization
Over the 1-year follow-up period, no significant differences
were foundbetween the two study groups in terms of cost per
patient for COPD-related or all-cause hospitalizations. Our
results are consistent with a recent systematic review from
Adams and colleagues25 which showed that the relative risk
for hospitalization was not significantly different between
the intervention and control groups in studies that provided
only one chronic care model (CCM) component (self-
management alone). In contrast, the pooled results fromrandomized controlled studies5,8,26,27 that implemented
multiple CCM components (interventions on delivery system
design, decision support, or clinical information systems)
demonstrated significant reductions in hospitalizations in
the intervention groups (relative risk (95%CI), 0.78
(0.66e0.94)). So far, only the study published by Bourbeau
et al.5 demonstrated the cost-effectiveness of a self-
management education program (reduction in respiratory-
related hospital admission and emergency department visits
per person and per year). They combined self-management
program with interventions on delivery system design and
decision support. A recent Dutch paper28 highlights the
mechanisms, nested in the social learning theory, that may
explain the added value of such programs, called disease-
management or integrated programs, which combined
patient-related and professional-directed interventions.
The patient-professional partnership implies that while
professionals are experts about diseases, patients are
experts about their own lives. For patients, the provision of
knowledge should lead to enhanced self-efficacy, which in
turn influences health behavior and eventually health status.
For professionals, access to decision support should affect
professional behavioral intention, which in turn influences
professional behavior and eventually leads to improved
health outcomes. When informed, patients take an active
role in managing their health, and professionals feel
prepared and supported with time and resources, thus likely
rendering their interaction to bemuchmore productive. The
effects of a self-management program on healthcare utili-
zation are hypothesized to result from behavioral change,
which in turn is caused by enhanced self-efficacy, knowledge
and skills.29 Although our programprovided exercise sessions
combined with education, patient-related intervention is
definitely insufficient, in particular without active sustained
follow-up, for leading to strong behavioral change and
reduction inutilizationof healthcare services.30Moreover, as
provided in the respiratory rehabilitation programs, the
psychological support is a key core-component of the
patient-related intervention to optimize the adoption and
maintenance of healthy behaviours.31Health-related quality of life and cost
Regarding HRQoL scores, after adjustment for baseline
values, significant between-group differences were found
only for the energy and emotional reaction dimensions of
the NHP and the SGRQ-symptom score. These two dimen-
sions of the NHP have been shown in prior studies to vary
more in response to pulmonary rehabilitation32 or other
professional-related interventions33 in COPD patients. The
emotional reaction dimension that is close to the concept
of subjective tension, and the energy dimension, are widely
described in literature as two important factors in the
mechanisms explaining the benefits of moderate exercise
on mood.34 Therefore, the significant improvement of
scores on these dimensions is very interesting. It suggests
changes in the behavior of patients with an increased daily
physical activity (supported by change of Voorrips total
scores, þ4.1 points), which in turn leads to an increased
subjective energy and tension reduction, two basic
elements of a good mood.
384 G. Ninot et al.Although insufficient to lead to significant or clinically
relevant between-group differences on the SGRQ-domain
physical activity (2.8; 95% CI (13 to 7 units)), the
benefits seen at 12 month in the energy and tension
dimensions are associated with lower perceived symptoms
measured by the SGRQ (14.0; 95% CI (23 to 5 units)).
These results concerning SGRQ-symptom scores are orig-
inal, compared to the pooled summary estimate for mean
change calculated in the review of Effing et al. (1.4; 95%
CI (4 to 1 units)).2 However, they are consistent with the
results reported by Boxal et al., who also provided super-
vised exercise sessions within the self-management
education program.6 This emphasizes the importance of
exercise to act on the determinants of mood, such as
energy and tension; mood that may bias symptom report-
ing.35 This change in perception of respiratory symptoms
may explain the reduction observed in mean cost of COPD
medication in favor of the intervention group (481; 95% CI
(891 to 70 V) per patient and per year). Mood is strongly
associated with investment beliefs,36 which have been
shown as the primary predictor of physically active
behavior37; thus the encouraging changes in two important
elements of mood that we observed one year after a short
self-management education intervention should be verified
with a longer follow-up period.
Limitations of study
Factors that need to be considered in the interpretation of
our findings include insufficient power and potential bia-
ses. The actual power to detect a clinically important
change (i.e. four points or greater) in the SGRQ was low
(13%). Our failure to detect statistically significant
between-group differences in the SGRQ-domain impact
and activity was thus likely limited by sample sizes, since
the direction and magnitude of treatment effects consis-
tently approached values that are considered to be clini-
cally important. Moreover, because of the low occurrence
of emergency department utilization and hospitalizations,
the power to detect differences between the groups for
these outcomes was even lower. Although this was
a randomized trial, a few baseline characteristics were not
equally distributed among the experimental groups. For
this reason, we used multivariate analysis to adjust for
these baseline differences. In addition, our study did not
report measures on determinants of behavioral change. As
such, more attention should be paid to the patterns of
physical activity with process indicators (i.e. knowledge,
psychosocial beliefs and self-efficacy) e since they
determine behavioral change, which in turn determines
clinical and quality of life outcomes.29, 37 Moreover, these
indicators may be more sensitive in capturing relevant
changes specific to self-management, and reduce the risk
of false-negative results.29 Finally, we cannot exclude the
presence of an attrition bias since seven patients allocated
in each group were not available for the evaluation at 1
year. However, this potential bias is minimized given their
comparable baseline characteristics with patients who
completed the follow-up. Moreover, the frequency and the
causes of dropping out were comparable between the
intervention groups.Conclusion
The results of our investigation show that a sensitizing
intervention that combined 8 exercise sessions with a self-
management education program is suitable for improving
patient skills over a 1-year period. It provides clinically
significant improvements in patient’s exercise tolerance
and HRQoL, and reductions in cost of COPD medications,
compared to usual care. The education component within
a self-management program should not be considered as an
isolated intervention. Clinicians should consider adding
supervised exercise to change patients’ habits and enable
them to learn ways to get desensitized to the sensation of
dyspnea and to the fear of physical exertion (also called
kinesiophobia).24
The absence of relevant results concerning hospital
admissions suggest that a self-management programhas to be
part of an integrated care system which consists of multiple
interventions at different levels (i.e. the patient, profes-
sionals and/or the organizational level).25,29,38 Achieving
behavioral changes inpatientsaswell asprofessionals appears
essential for substantially changing the partnership dynamic
between patients and care providers, and patient self-
management behaviour. To this end, organizational structure
should also be modified to include case management, follow-
up systems and/or multidisciplinary care provision.Acknowledgements
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